Risk factors for gastrointestinal stromal tumor recurrence in patients treated with adjuvant imatinib-Reference-Cited by-同舟云学术

Risk factors for gastrointestinal stromal tumor recurrence in patients treated with adjuvant imatinib

Published:2014-04-15 Issue:15 Volume:120 Page:2325-2333
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Joensuu Heikki¹,Eriksson Mikael²,Hall Kirsten Sundby³,Hartmann Jörg T.⁴,Pink Daniel⁵,Schütte Jochen⁶,Ramadori Giuliano⁷,Hohenberger Peter⁸,Duyster Justus⁹,Al‐Batran Salah‐Eddin¹⁰,Schlemmer Marcus¹¹,Bauer Sebastian¹²,Wardelmann Eva¹³,Sarlomo‐Rikala Maarit¹⁴,Nilsson Bengt¹⁵,Sihto Harri¹⁶,Ballman Karla V.¹⁷,Leinonen Mika¹⁸,DeMatteo Ronald P.¹⁹,Reichardt Peter⁵

Affiliation:

1. Department of OncologyHelsinki University Central HospitalHelsinki Finland

2. Department of Oncology, Skåne University HospitalLund UniversityLund Sweden

3. Department of Oncology, The Norwegian Radium HospitalOslo University HospitalOslo Norway

4. Section of Medical Oncology, Medical Center 2Christian‐Albrechts‐UniversityKiel Germany

5. Sarkomzentrum Berlin‐BrandenburgHELIOS Klinikum Berlin‐BuchBerlin Germany

6. Schwerpunktpraxis für Onkologie Hämatologie und ambulante TumortherapieDüsseldorf Germany

7. Department of Gastroenterology/EndocrinologyUniversity of GöttingenGöttingen

8. Division of Surgical Oncology and Thoracic SurgeryMannheim University Medical CenterMannheim Germany

9. III Medizinischen KlinikKlinikum rechts der IsarMunich Germany

10. Klinik für Onkologie und Hämatologie amKrankenhaus Nordwest, Frankfurt Germany

11. Department of Internal Medicine IIIUniversity Hospital‐Großhadern, Ludwig Maximilians UniversityMunich Germany

12. Sarcoma Center, West German Cancer CenterUniversity of Duisburg‐EssenEssen Germany

13. Gerhard Domagk Institute of PathologyUniversity Hospital MuensterMuenster Germany

14. Department of PathologyHelsinki University Central HospitalHelsinki Finland

15. Department of SurgerySahlgrenska University HospitalGothenburg Sweden

16. Laboratory of Molecular OncologyBiomedicum, University of HelsinkiHelsinki Finland

17. Mayo ClinicRochester Minnesota

18. 4Pharma LtdTurku Finland

19. Memorial Sloan Kettering Cancer Center, New YorkNew York

Funder

Academy of Finland

Cancer Society of Finland

Helsinki University Research Funds

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cncr.28669

Reference19 articles.

1. Gastrointestinal stromal tumours: origin and molecular oncology

2. Gastrointestinal stromal tumour

3. PDGFRA Activating Mutations in Gastrointestinal Stromal Tumors

4. Gain-of-function mutations of platelet-derived growth factor receptor α gene in gastrointestinal stromal tumors

5. Gastrointestinal stromal tumors: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Cited by 64 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Precision Oncology in Soft Tissue Sarcomas and Gastrointestinal Stromal Tumors;Surgical Oncology Clinics of North America;2024-01

2. Assessing prognostic factors of long‐term survival after surgery for colorectal gastrointestinal stromal tumours;Colorectal Disease;2023-10-24

3. Cost Evaluation Analysis of Genetic Testing and Tailored Adjuvant Imatinib in Patients With Resected High-Risk GI Stromal Tumors: The Brazilian Perspective;JCO Global Oncology;2023-09

4. KIT and PDGFRA Variants and the Survival of Patients with Gastrointestinal Stromal Tumor Treated with Adjuvant Imatinib;Cancers;2023-07-30

5. Microvessel density in patients with gastrointestinal stromal tumors: A systematic review and meta-analysis;World Journal of Methodology;2023-06-20